Cargando…

Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?

No abstract. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-014-0457-z) contains supplementary material, which is available to authorized users.

Detalles Bibliográficos
Autor principal: Klinke, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303193/
https://www.ncbi.nlm.nih.gov/pubmed/25927347
http://dx.doi.org/10.1186/s13058-014-0457-z
_version_ 1782353903285698560
author Klinke, David J
author_facet Klinke, David J
author_sort Klinke, David J
collection PubMed
description No abstract. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-014-0457-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4303193
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43031932015-01-23 Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer? Klinke, David J Breast Cancer Res Letter No abstract. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-014-0457-z) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-07 2014 /pmc/articles/PMC4303193/ /pubmed/25927347 http://dx.doi.org/10.1186/s13058-014-0457-z Text en © Klinke; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Klinke, David J
Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?
title Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?
title_full Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?
title_fullStr Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?
title_full_unstemmed Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?
title_short Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?
title_sort is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303193/
https://www.ncbi.nlm.nih.gov/pubmed/25927347
http://dx.doi.org/10.1186/s13058-014-0457-z
work_keys_str_mv AT klinkedavidj isimmunecheckpointmodulationapotentialtherapeuticoptionintriplenegativebreastcancer